Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective

Recent Alzheimer's trials have recruited cognitively normal people at risk for Alzheimer's dementia. Due to the lack of clinical symptoms in normal population, conventional clinical outcome measures are not suitable for these early trials. While several groups are developing new composite...

Descripción completa

Detalles Bibliográficos
Autores principales: Shokouhi, Sepideh, Campbell, Desmond, Brill, Aaron B., Gwirtsman, Harry E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Mini‐symposium: Energy Demand and Energy Supply in Alzheimer's Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958602/
https://www.ncbi.nlm.nih.gov/pubmed/27327527
http://dx.doi.org/10.1111/bpa.12399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958602/
https://www.ncbi.nlm.nih.gov/pubmed/27327527
http://dx.doi.org/10.1111/bpa.12399

Ejemplares similares